Genitourinary syndrome of menopause (GSM)

The term "genitourinary syndrome of menopause" might be unfamiliar, but if you're experiencing vaginal dryness, irritation, urinary urgency, recurrent UTIs, or pain with intercourse, you're experiencing GSM. It's not a collection of separate problems, it's a single condition affecting multiple interconnected tissues. Understanding GSM as an integrated condition, recognizing that it's progressive without treatment, and knowing that effective treatments exist, changes how you approach managing it.

Key Facts

• GSM is the umbrella term for all estrogen-related changes in vaginal, vulvar, and urinary tissues
• 50-70% of postmenopausal women have GSM to some degree, though only 40-54% experience bothersome symptoms
• GSM symptoms typically worsen over time without treatment, unlike other menopause symptoms that often improve
• The vaginal changes underlying GSM are structural, not psychological, and require treatment, not patience
• Multiple symptoms often occur together (dryness, urgency, painful intercourse) because they share a common cause: estrogen loss
• Vaginal estrogen is the most effective first-line treatment and is safe long-term
• GSM significantly impacts sexual function, intimacy, and quality of life, making treatment important for relationship health
• GSM is progressive, meaning the longer you go without treatment, the more significant the tissue changes become

What Is Genitourinary Syndrome of Menopause?

GSM is a clinical term coined in 2014 by the International Society for the Study of Women's Sexual Health and the North American Menopause Society to describe the constellation of symptoms and tissue changes resulting from estrogen loss in the genitourinary tract. Previously, it was called vaginal atrophy, atrophic vaginitis, or urogenital atrophy, terms that focused only on dryness. GSM better describes the full spectrum of changes affecting vaginal, vulvar, urethral, and bladder tissues.

The condition is caused by and directly results from declining estrogen. The tissues lining the vagina, vulva, and urethra are estrogen-dependent, meaning they contain high numbers of estrogen receptors. When estrogen drops during menopause, these tissues undergo predictable changes.

The vaginal lining becomes thinner and loses elasticity. The tissue becomes more fragile, easily irritated, and prone to bleeding. Blood vessels decrease, reducing oxygen and nutrient supply to tissues. Vaginal glands that produce lubrication produce less. The vaginal environment becomes less acidic, disrupting the protective lactobacilli and increasing susceptibility to infection. Similar changes occur in the vulva and in tissues lining the urethra and bladder, creating urinary symptoms.

Importantly, GSM is progressive. Unlike hot flashes, which often peak during perimenopause and gradually improve, GSM typically worsens over time without treatment. The longer tissues are estrogen-deprived, the more structural changes occur. This is why early treatment is important: restoring estrogen early can reverse some changes, whereas waiting years makes reversal more difficult.

Symptoms of GSM

GSM manifests as a cluster of related symptoms affecting different tissues:

Vaginal dryness is the hallmark symptom. Women describe inadequate vaginal moisture for comfort, lack of natural lubrication, or a feeling of dryness even during arousal when they used to produce natural lubrication.

Vaginal itching and burning often accompany dryness. The itching can range from mild and occasional to intense and persistent. Some women describe a raw or sandpaper-like sensation.

Vulvar irritation and discomfort extends beyond vaginal symptoms. The vulva may feel irritated, sore, or inflamed.

Pain with sexual intercourse (dyspareunia) is frequently the symptom that prompts women to seek treatment. Sexual penetration may cause sharp, burning, or stretching pain. The pain can be at entry, deep inside, or throughout sexual contact. Some women lose sexual interest because of pain concerns.

Urinary symptoms including urgency (needing to urinate frequently and with sudden urge), frequency (more than 8 times daily or more than 2 times nightly), and burning with urination are common. Some women develop urge incontinence (leakage with sudden urge).

Recurrent urinary tract infections happen because the altered vaginal environment and incomplete bladder emptying create favorable conditions for bacterial overgrowth.

Reduced lubrication during sexual arousal means that even with increased blood flow and sexual response, natural lubrication doesn't occur as it did during reproductive years.

Loss of elasticity creates a feeling that the vagina is narrower or tighter than before. Sexual penetration that once felt natural now feels uncomfortable.

Watery vaginal discharge sometimes occurs, though many women experience the opposite: no discharge at all.

The severity and combination of symptoms varies widely. Some women experience primarily dryness and discomfort. Others have significant urinary symptoms. Many experience multiple symptoms simultaneously.

Why It Happens

Estrogen is essential for maintaining the health and function of vaginal, vulvar, and urinary tissues. During reproductive years, consistent estrogen production maintains the thickness, elasticity, and lubrication of vaginal tissue. The vaginal environment is acidic (pH 3.5-4.5) due to lactobacilli (healthy bacteria), which protect against infection.

When estrogen drops during menopause (by about 90%), several coordinated changes occur:

Vaginal epithelium thins, losing the protective multiple layers of cells. The tissue becomes more fragile, easily irritated, and prone to bleeding with minor trauma (like intercourse).

Collagen and elastin decrease, so tissue loses its stretch and resilience. Tissue becomes stiff and less able to accommodate.

Blood vessels become fewer and less active, reducing blood flow, oxygen delivery, and nutrient supply to tissues. Reduced blood flow impairs the tissue's ability to repair itself and produce moisture.

Vaginal pH becomes more alkaline (rises to 5.0-7.0), disrupting the protective lactobacilli and increasing vulnerability to bacterial overgrowth.

Vaginal glands produce less lubrication because these glands are estrogen-dependent and require adequate estrogen to function.

Urethra and bladder undergo similar changes, becoming thinner and less elastic, reducing bladder capacity and creating urgency and frequency.

These are structural changes to living tissue, not cosmetic issues or psychological symptoms. The tissue is objectively thinner, less elastic, and less vascularized when examined under magnification. Treatment works because it addresses these actual tissue changes.

What You Can Do

Management of GSM exists on a spectrum from simple daily practices to prescription medications.

Regular sexual activity has genuine therapeutic benefit. Sexual arousal increases blood flow to vaginal tissue, improves oxygenation, promotes new cell growth, and stimulates the glands that produce natural lubrication. Masturbation, partnered sex, and other sexual activities all provide these benefits. If pain is preventing sexual activity, starting other treatment first enables returning to sexual activity, which then becomes part of ongoing management.

Staying hydrated supports overall tissue health. Systemic hydration contributes to vaginal moisture production, though it's not a cure for estrogen-related dryness.

Vaginal moisturizers hydrate vaginal tissue on an ongoing basis. These products are designed to be used regularly (every few days, with or without sexual activity) to maintain moisture. Water-based and hyaluronic acid-based moisturizers absorb into tissue and provide sustained hydration. These are non-hormonal and can be used long-term.

Vaginal lubricants are applied right before sexual activity to reduce friction and discomfort. Water-based and silicone-based lubricants provide immediate comfort. These are not a cure but symptom management.

Avoiding irritants prevents worsening. This means avoiding douches, scented products, tight synthetic underwear, and irritating soaps. The vagina is self-cleaning and requires only warm water for external washing.

For many women, starting with moisturizers and lubricants is reasonable. However, if symptoms don't improve after 2-4 weeks of consistent use, prescription treatments should be discussed, as they're more effective for moderate to severe symptoms.

Treatment Options

Vaginal estrogen is the most effective treatment and is considered the gold standard. It directly addresses the underlying cause: low local estrogen. Vaginal estrogen comes in several forms:

Creams (estradiol or conjugated estrogens) are applied internally, typically daily for 2 weeks, then 2-3 times weekly. They're effective but require consistency and can be messy.

Tablets (estradiol) are inserted vaginally and dissolve, providing steady hormone delivery. They're convenient, typically requiring 2-3 applications weekly after an initial daily phase.

Rings (estradiol) are placed in the vagina and release estrogen continuously, requiring replacement only every 3 months. They provide steady dosing without frequent application.

Vaginal estrogen is safe for long-term use. While systemic absorption occurs, it's much lower than oral HRT. Even women who cannot take systemic HRT can safely use vaginal estrogen.

Systemic HRT treats GSM alongside other menopausal symptoms when multiple symptoms are present. It takes 4-12 weeks to show benefits for vaginal symptoms.

DHEA (prasterone) is a vaginal suppository containing a hormone precursor to estrogen and testosterone. It improves vaginal tissue and sexual function. It's applied nightly and is an option for women who cannot use estrogen.

Ospemifene is an oral medication acting like estrogen in vaginal tissue but having different effects elsewhere. It helps with pain with intercourse and dryness. It carries similar blood clot warnings as systemic HRT.

Vaginal laser therapy is sometimes marketed for GSM, though evidence for benefit is limited. The FDA has not approved laser treatments specifically for GSM, clinical evidence is mixed, and results vary. It's not considered first-line treatment.

Combination approaches are often most effective. Many women use vaginal moisturizer daily, lubricant with sexual activity, and vaginal estrogen several times weekly, with synergistic benefit.

When to Seek Care

Schedule an appointment with your gynecologist if you're experiencing:

Significant vaginal dryness or irritation affecting comfort or quality of life.

Pain with sexual intercourse that's interfering with intimacy or relationship.

Urinary urgency, frequency, or recurrent UTIs that coincide with vaginal symptoms. Treating underlying GSM often resolves these.

Symptoms worsening despite over-the-counter moisturizers and lubricants after 2-4 weeks of consistent use.

Vaginal bleeding or spotting during or after intercourse, which, while often caused by fragile tissue from GSM, requires evaluation to rule out other causes.

Your healthcare provider can confirm GSM diagnosis (usually based on symptoms and examination), rule out other causes of symptoms like infections or other conditions, and recommend appropriate treatment based on symptom severity and your preferences.

Prevention and Long-Term Management

Because GSM is progressive without treatment, early management is important. Women with mild dryness who start using moisturizers early often prevent symptoms from worsening. Those who wait may develop severe tissue changes requiring more intensive treatment.

GSM typically requires ongoing management because it's caused by ongoing low estrogen. When treatment stops, symptoms usually return. This doesn't mean treatment failed, it means your body still has low estrogen. Many women continue vaginal estrogen long-term, decades beyond the initial menopause years, as a normal part of postmenopausal health maintenance.

How Menovita Can Help

Tracking your vaginal and urinary symptoms in Menovita helps you notice patterns and quantify severity. You can record dryness, irritation, pain with intercourse, and urinary symptoms to show your healthcare provider, supporting clearer communication about what's affecting you. You'll also find detailed information about every treatment option so you can have informed conversations about what's right for your body and your life.

Frequently Asked Questions

Is GSM the same as vaginal dryness?

Dryness is one symptom of GSM, but GSM is broader. It includes dryness, irritation, painful intercourse, urinary symptoms, and the underlying tissue changes. A woman might have all these symptoms together or just a few. GSM is the umbrella term for the whole cluster of estrogen-related genitourinary changes.

Will my symptoms improve on their own?

Unlikely without treatment. Unlike hot flashes, which often improve over time, GSM typically worsens without treatment. Early treatment is important to prevent progressive tissue damage. The longer you wait, the more structural changes occur and the harder they are to reverse.

Is vaginal estrogen safe if I can't take systemic HRT?

Yes. Vaginal estrogen is safe even for women with contraindications to systemic HRT like history of blood clots or certain cancers. The absorbed amount is much lower than oral HRT, making it appropriate when systemic hormone therapy is not.

How long before treatment works?

Moisturizers and lubricants provide immediate comfort but require ongoing use. Vaginal estrogen typically takes 2-3 weeks to show improvement, with continued improvement at 12 weeks. Oral medications take 6-12 weeks to reach full effect. Sexual function improvements often take longer than symptom relief.

Do I need to take time off work to use vaginal estrogen treatments?

No. Creams might cause minor discharge but can be managed easily. Tablets and rings are discrete and don't interfere with daily activities. Choose the form that fits best with your lifestyle.